|
시장보고서
상품코드
2039058
만성 구내염 치료 시장 : 진단법별, 치료법별, 최종사용자별, 지역별Chronic Gingivostomatitis Treatment Market, By Diagnosis, By Treatment, By End User, By Geography |
||||||
만성 구내염 치료 시장은 2026년에 201억 달러로 추정되며, 2033년까지 312억 달러에 이를 것으로 예상되고 있습니다. 또한 2026-2033년 CAGR은 6.5%를 보일 전망입니다.
| 분석 범위 | 분석 상세 | ||
|---|---|---|---|
| 기준 연도 | 2025년 | 시장 규모(2026년) | 201억 달러 |
| 실적 데이터 | 2020-2024년 | 예측 기간 | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR | 6.50% | 예측 금액(2033년) | 312억 달러 |
치은구내염은 혀와 구개에 통증과 함께 궤양, 물집, 부종을 유발하는 전염성 구강 감염 질환입니다. 보통 감염자의 타액이나 병변, 궤양과의 직접적인 접촉을 통해 감염이 확산됩니다. 치은구내염은 헤르페스성이라고도 하며, 단순 포진 바이러스에 의해 발생하며, 치은구내염의 가장 흔한 원인입니다. 치은구내염은 보통 6세 미만의 유아에게 가장 많이 발생하지만, 성인에게도 발병할 수 있습니다. 노인의 경우 성인이나 어린이보다 더 심각한 증상이 나타날 수 있습니다.
시장 역학
단순 헤르페스 바이러스(HSV)에 의한 치은구내염 발생률 증가가 만성 치은구내염 치료제 시장의 성장을 견인할 것으로 예측됩니다. 예를 들어, 2016년 10월 'International Journal of Dentistry'에 게재된 논문에 따르면 치은구내염의 90% 이상이 단순 헤르페스 바이러스(HSV) 1형에 의해 발생하며, 나머지는 단순 헤르페스 바이러스(HSV) 2형에 의한 것으로 보고되었습니다. 에 의한 것으로 보고되고 있습니다.
그러나 만성 치은구내염에 대한 정확한 파악과 진단이 이루어지지 않는 것이 시장 성장을 저해할 것으로 예측됩니다. 예를 들어, 2017년 발표된 'Journal of Dental Health Oral Disorders &Therapy' 논문에 따르면 만성 치은구내염은 무증상인 경우도 있고, 자각하지 못하거나 다른 만성구내염으로 오진되는 경우도 있다고 합니다.
본 보고서의 주요 특징
- 이 보고서는 각 부문의 잠재적 수익 기회를 밝히고 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한, 시장 촉진 및 억제요인 및 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 업체들의 경쟁 전략 등에 대한 중요한 고찰을 제공합니다.
- 세계 만성 치은구내염 치료제 시장의 주요 기업 프로파일을 기업 개요, 제품 포트폴리오, 주요 특징, 재무 실적, 전략 등 다양한 매개변수를 기반으로 정리하여 수록하였습니다.
- 이 보고서의 인사이트를 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형 업데이트, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
- "세계 만성 치은염 치료 시장" 보고서는 투자자, 공급업체, 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 만성 치은구내염 치료제 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.
목차
제1장 분석 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 만성 구내염 치료 시장 : 진단법별(2021년-2033년)
제5장 세계의 만성 구내염 치료 시장 : 치료법별(2021년-2033년)
제6장 세계의 만성 구내염 치료 시장 : 최종사용자별(2021년-2033년)
제7장 세계의 만성 구내염 치료 시장 : 지역별(2021년-2033년)
제8장 경쟁 구도
제9장 섹션
LSH 26.06.04Chronic Gingivostomatitis Treatment Market is estimated to be valued at USD 20,100 Mn in 2026 and is expected to reach USD 31,200 Mn by 2033, growing at a compound annual growth rate (CAGR) of 6.5% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 20,100 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 6.50% | 2033 Value Projection: | USD 31,200 Mn |
Gingivostomatitis is a contagious mouth infection, which causes painful sores, blisters, and swelling in the tongue and uvula. It usually spreads through the saliva of an infected individual or by direct contact with a lesion or sore. Gingivostomatitis is also called as herpetic, which is caused by herpes simplex virus and is the most common cause of gingivostomatitis. Gingivostomatitis is the most common among young children, usually under 6 years old, but it may also occur in adults. Geriatric people may experience severe symptoms than adults and children.
Market Dynamics
Rising incidence of gingivostomatitis caused by herpes simplex virus (HSV) is expected to drive the chronic gingivostomatitis treatment market growth. For instance, according to the International Journal of Dentistry, an article published in October 2016, reports that over 90% of gingivostomatitis cases are caused by herpes simplex virus (HSV) type 1 and the remainder are caused by herpes simplex virus (HSV) type 2.
However, lack of identification or diagnosis of chronic gingivostomatitis are expected to hinder the market growth. For instance, according to the Journal of Dental Health Oral Disorders & Therapy, an article published in 2017, states that chronic gingivostomatitis may be asymptomatic in some instances, may be unnoticed in some instances, and sometimes get misdiagnosed with other chronic mouth ulcers.
Key features of the study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global chronic gingivostomatitis treatment market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
- Key companies covered as a part of this study are Pfizer Inc., Taj Pharmaceutical limited, Ciron pharma, Johnson & Johnson, GlaxoSmithKline PLC, Merck & CO., Inc., Novartis AG, F. Hoffman La Roche AG, Eli Lily and Company, and AstraZeneca Plc. among others
- Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding future drug launches, drug class up-gradation, market expansion, and marketing tactics
- The global chronic gingivostomatitis treatment market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global chronic gingivostomatitis treatment market
Market Segmentation
- By Diagnosis (Revenue, USD Mn, 2021-2033)
- Physical Examination
- Microbial Culture
- Biopsy
- Others
- By Treatment (Revenue, USD Mn, 2021-2033)
- Non-steroidal Anti-inflammatory Drugs
- Antiviral
- Antibacterial
- Others
- By End User (Revenue, USD Mn, 2021-2033)
- Hospitals & Clinics
- Academic & Research
- Others
- By Region (Revenue, USD Mn, 2021-2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
- Key Players
- Pfizer Inc.
- Taj Pharmaceutical Limited
- Ciron Pharma
- Johnson & Johnson
- GlaxoSmithKline PLC
- Merck & Co., Inc.
- Novartis AG
- Hoffmann-La Roche AG
- Eli Lilly and Company
- AstraZeneca Plc.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Diagnosis
- Market Snippet, By Treatment
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Pipeline Analysis
- Reimbursement Scenario
- Epidemiology
- Pest Analysis
- Regulatory Scenario
- New Product Launches
- Collaborations and Agreements
- Market Trends
4. Global Chronic Gingivostomatitis Treatment Market, By Diagnosis, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026, and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Physical Examination
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Microbial Culture
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Biopsy
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Others
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
5. Global Chronic Gingivostomatitis Treatment Market, By Treatment, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026, and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Non-steroidal Anti-inflammatory Drugs
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Antiviral
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Antibacterial
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Others
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
6. Global Chronic Gingivostomatitis Treatment Market, By End User, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026, and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospitals & Clinics
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Academic & Research
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Others
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
7. Global Chronic Gingivostomatitis Treatment Market, By Region, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, By Region, 2026, and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2022 - 2033
- North America
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Diagnosis, 2021-2033, (USD Mn)
- Market Size and Forecast, By Treatment, 2021-2033, (USD Mn)
- Market Size and Forecast, By End User, 2021-2033, (USD Mn)
- Market Size and Forecast, By Country, 2021-2033, (USD Mn)
- U.S.
- Canada
- Latin America
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Diagnosis, 2021-2033, (USD Mn)
- Market Size and Forecast, By Treatment, 2021-2033, (USD Mn)
- Market Size and Forecast, By End User, 2021-2033, (USD Mn)
- Market Size and Forecast, By Country, 2021-2033, (USD Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Diagnosis, 2021-2033, (USD Mn)
- Market Size and Forecast, By Treatment, 2021-2033, (USD Mn)
- Market Size and Forecast, By End User, 2021-2033, (USD Mn)
- Market Size and Forecast, By Country, 2021-2033, (USD Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Diagnosis, 2021-2033, (USD Mn)
- Market Size and Forecast, By Treatment, 2021-2033, (USD Mn)
- Market Size and Forecast, By End User, 2021-2033, (USD Mn)
- Market Size and Forecast, By Country, 2021-2033, (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Diagnosis, 2021-2033, (USD Mn)
- Market Size and Forecast, By Treatment, 2021-2033, (USD Mn)
- Market Size and Forecast, By End User, 2021-2033, (USD Mn)
- Market Size and Forecast, By Country, 2021-2033, (USD Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Diagnosis, 2021-2033, (USD Mn)
- Market Size and Forecast, By Treatment, 2021-2033, (USD Mn)
- Market Size and Forecast, By End User, 2021-2033, (USD Mn)
- Market Size and Forecast, By Country, 2021-2033, (USD Mn)
- South Africa
- Central Africa
- North Africa
8. Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
- Pfizer Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Taj Pharmaceutical limited
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Ciron pharma
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Johnson & Johnson
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- GlaxoSmithKline PLC
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Merck & CO., Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Novartis AG
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Hoffman La Roche AG
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Eli Lily and Company
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- AstraZeneca Plc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Analyst Views
- Pfizer Inc.
9. Section
- References
- Research Methodology
- About us and Sales Contact
